205 results
Page 4 of 11
424B3
imtg7ueut7gft5bq
8 May 19
Prospectus supplement
12:00am
S-4/A
6d9rjhzzpcw
3 May 19
Registration of securities issued in business combination transactions (amended)
9:51pm
S-4
7pt2wg61fd rx5lv
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
425
q9r1van6g0zuwd w7
7 Mar 19
Business combination disclosure
5:12pm
8-K
EX-99.1
kr7uwp se1ita6cjef
7 Mar 19
Entry into a Material Definitive Agreement
7:33am
425
EX-99.1
zjyqkjwwj4g6byyqce
7 Mar 19
Business combination disclosure
7:31am
8-K
EX-99.1
lxfbe7ahru33nkin
22 Oct 18
GTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update
7:30am
8-K
c35n927a
21 Sep 18
GTx Announces Top-Line Results from Placebo-Controlled ASTRID Trial of Enobosarm in Women with Stress Urinary Incontinence
8:30am
8-K
EX-99.1
d2deui3sa1cn r5dk
21 Sep 18
GTx Announces Top-Line Results from Placebo-Controlled ASTRID Trial of Enobosarm in Women with Stress Urinary Incontinence
8:30am
8-K
EX-99.1
f31ck a148m
14 Aug 18
GTx Provides Corporate Update and Reports Second Quarter 2018 Financial Results
7:30am
8-K
e79ygu
18 May 18
GTx Updates Phase 2 Enobosarm Clinical Trial Results in Stress Urinary Incontinence at 2018 AUA Annual Meeting
2:40pm
8-K
EX-99.1
6msppd2ldru w7jmibb
18 May 18
GTx Updates Phase 2 Enobosarm Clinical Trial Results in Stress Urinary Incontinence at 2018 AUA Annual Meeting
2:40pm
8-K
EX-99.1
r33q2pow6y40lcx0j1
15 May 18
GTx Provides Corporate Update and Reports First Quarter 2018 Financial Results
7:15am